Modeling infectious disease dynamics in the complex landscape of global health

Science

Volumn 347, Issue 6227, 2015, Pages

  Heesterbeek, Hans ^a   Anderson, Roy M ^b   Andreasen, Viggo ^c   Bansal, Shweta ^d   DeAngelis, Daniela ^e   Dye, Chris ^f   Eames, Ken T D ^g   Edmunds, W John ^g   Frost, Simon D W ^h   Funk, Sebastian ^d   Hollingsworth, T Deirdre ^i,j   House, Thomas ^k   Isham, Valerie ^l   Klepac, Petra ^h   Lessler, Justin ^m   Lloyd Smith, James O ⁿ   Metcalf, C Jessica E ^o,p   Mollison, Denis ^q   Pellis, Lorenzo ^k   Pulliam, Juliet R C ^r,s   Roberts, Mick G ^t   Viboud, Cecile ^s   Arinaminpathy, Nimalan ^b   Ball, Frank ^u   Bogich, Tiffany ^p   Gog, Julia ^h   Grenfell, Bryan ^p   Lloyd, Alun L ^v   Mclean, Angela ^o   O'Neill, Philip ^u   Pearson, Carl ^r   Riley, Steven ^b   Tomba, Gianpaolo Scalia ^w   Trapman, Pieter ^x   Wood, James ^y   more..

^a UTRECHT UNIVERSITY   (Netherlands)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROSKILDE UNIVERSITY   (Denmark)

^d GEORGETOWN UNIVERSITY   (United States)

^e MRC BIOSTATISTICS UNIT   (United Kingdom)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ UNIVERSITY OF WARWICK   (United Kingdom)

^j LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^k UNIVERSITY OF WARWICK   (United Kingdom)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p PRINCETON UNIVERSITY   (United States)

^q HERIOT WATT UNIVERSITY   (United Kingdom)

^r UNIVERSITY OF FLORIDA   (United States)

^s NATIONAL INSTITUTES OF HEALTH   (United States)

^t MASSEY UNIVERSITY   (New Zealand)

^u UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^v NORTH CAROLINA STATE UNIVERSITY   (United States)

^w SAPIENZA UNIVERSITY OF ROME   (Italy)

^x STOCKHOLM UNIVERSITY   (Sweden)

^y University of Florida ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROPOD; DECISION MAKING; DISEASE CONTROL; DISEASE TRANSMISSION; DISEASE VECTOR; HEALTH RISK; INFECTIOUS DISEASE; NATIONAL PLANNING; NUMERICAL MODEL; PATHOGEN; RESERVOIR;

ANTIBIOTIC RESISTANCE; DISEASE MODEL; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; HEALTH; HEALTH CARE POLICY; HOST; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; MATHEMATICAL MODEL; NONHUMAN; PARASITE VECTOR; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; ANIMAL; BASIC REPRODUCTION NUMBER; BIOLOGICAL MODEL; COMMUNICABLE DISEASES; COMMUNICABLE DISEASES, EMERGING; HEMORRHAGIC FEVER, EBOLA; MIXED INFECTION; TRANSMISSION; ZOONOSES;

ANIMALIA; ARTHROPODA;

ANIMALS; BASIC REPRODUCTION NUMBER; COINFECTION; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; GLOBAL HEALTH; HEALTH POLICY; HEMORRHAGIC FEVER, EBOLA; HUMANS; MODELS, BIOLOGICAL; PUBLIC HEALTH; ZOONOSES;

EID: 84924787757     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaa4339     Document Type: Review

References (133)

1. World Health Organization, Global strategy for health for all by the year 2000 (WHO, Geneva, 1981, http://whqlibdoc.who.int/publications/9241800038.pdf).
2. World Health Organization, Mortality and global health estimates 2013 (WHO, 2013, http://apps.who.int/gho/data/node.main.686?lang=en.).
3. P. Klepac, C. J. Metcalf, A. R. McLean, K. Hampson, Towards the endgame and beyond: Complexities and challenges for the elimination of infectious diseases. Philos. Trans. R. Soc. Lond. B 368, 20120137 (2013). doi: 10.1098/rstb.2012.0137; pmid: 23798686
4. P. Daszak, A. A. Cunningham, A. D. Hyatt, Emerging infectious diseases of wildlife-threats to biodiversity and human health. Science 287, 443-449 (2000). doi: 10.1126/science.287.5452.443; pmid: 10642539
5. K. E. Jones et al ., Global trends in emerging infectious diseases. Nature 451, 990-993 (2008). doi: 10.1038/nature06536; pmid: 18288193
6. J. O. Lloyd-Smith et al., Epidemic dynamics at the human-animal interface. Science 326, 1362-1367 (2009). doi: 10.1126/science.1177345; pmid: 19965751
7. F. Keesing et al., Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 468, 647-652 (2010). doi: 10.1038/nature09575; pmid: 21124449
8. K. F. Smith et al., Global rise in human infectious disease outbreaks. J. R. Soc. Interface 11, 20140950 (2014). doi: 10.1098/rsif.2014.0950; pmid: 25401184
9. S. Funk, M. Salathé, V. A. A. Jansen, Modelling the influence of human behaviour on the spread of infectious diseases: A review. J. R. Soc. Interface 7, 1247-1256 (2010). doi: 10.1098/rsif.2010.0142; pmid: 20504800
10. C. T. Bauch, A. P. Galvani, Epidemiology. Social factors in epidemiology. Science 342, 47-49 (2013). doi: 10.1126/science.1244492; pmid: 24092718
11. E. M. Volz, K. Koelle, T. Bedford, Viral phylodynamics. PLOS Comput. Biol. 9, e1002947 (2013). doi: 10.1371/journal.pcbi.1002947; pmid: 23555203
12. D. Bernoulli, S. Blower, An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it. Rev. Med. Virol. 14, 275-288 (2004). Reprinted translation by L. Bradley with review by S. Blower; original in French 1766). doi: 10.1002/rmv.443; pmid: 15334536
13. J. O. Lloyd-Smith, D. Mollison, J. E. Metcalf, P. Klepac, J. A. P. Heesterbeek, Eds., Challenges in Modelling Infectious Disease Dynamics. Epidemics 10 (special issue, March 2015).
14. WHO Ebola Response Team, Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N. Engl. J. Med. 371, 1481-1495 (2014). doi: 10.1056/NEJMoa1411100; pmid: 25244186
15. S. K. Gire et al., Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345, 1369-1372 (2014). doi: 10.1126/science.1259657; pmid: 25214632
16. A. Camacho et al., Potential for large outbreaks of Ebola virus disease. Epidemics 9, 70-78 (2014). doi: 10.1016/j.epidem.2014.09.003; pmid: 25480136
17. A. Pandey et al., Strategies for containing Ebola in West Africa. Science 346, 991-995 (2014). doi: 10.1126/science.1260612; pmid: 25414312
18. C. J. M. Whitty et al., Infectious disease: Tough choices to reduce Ebola transmission. Nature 515, 192-194 (2014). doi: 10.1038/515192a; pmid: 25391946
19. 0 and transmission heterogeneity from the size distribution of stuttering chains. PLOS Comput. Biol. 9, e1002993 (2013). doi: 10.1371/journal.pcbi.1002993; pmid: 23658504
20. S. Cauchemez et al., Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: Application to the emergence of US swine origin influenza A H3N2v virus. PLOS Med. 10, e1001399 (2013). doi: 10.1371/journal.pmed.1001399; pmid: 23472057
21. A. Kucharski, H. Mills, A. Pinsent, C. Fraser, M. Van Kerkhove, C. A. Donnelly, S. Riley, Distinguishing between reservoir exposure and human-to-human transmission for emerging pathogens using case onset data. PLOS Curr. (2014). pmid: 24619563
22. O. Restif et al ., Model-guided fieldwork: Practical guidelines for multidisciplinary research on wildlife ecological and epidemiological dynamics. Ecol. Lett. 15, 1083-1094 (2012). doi: 10.1111/j.1461-0248.2012.01836.x; pmid: 22809422
23. S. Selakovic, P. C. de Ruiter, H. Heesterbeek, Infectious disease agents mediate interaction in food webs and ecosystems. Proc. Biol. Sci. 281, 20132709 (2014). doi: 10.1098/rspb.2013.2709; pmid: 24403336
24. R. K. Plowright et al., Ecological dynamics of emerging bat virus spillover. Proc. Biol. Sci. 282, 20142124 (2015). doi: 10.1098/rspb.2014.2124; pmid: 25392474
25. M. Cotten et al., Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio 5, e01062 (2014). doi: 10.1128/mBio.01062-13; pmid: 24549846
26. K. M. Pepin, S. Lass, J. R. Pulliam, A. F. Read, J. O. Lloyd-Smith, Identifying genetic markers of adaptation for surveillance of viral host jumps. Nat. Rev. Microbiol. 8, 802-813 (2010). doi: 10.1038/nrmicro2440; pmid: 20938453
27. B. T. Grenfell et al., Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303, 327-332 (2004). doi: 10.1126/science.1090727; pmid: 14726583
28. A. Rambaut et al., The genomic and epidemiological dynamics of human influenza A virus. Nature 453, 615-619 (2008). doi: 10.1038/nature06945; pmid: 18418375
29. J. L. Gardy et al., Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N. Engl. J. Med. 364, 730-739 (2011). doi: 10.1056/NEJMoa1003176; pmid: 21345102
30. H. W. Stokes, M. R. Gillings, Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiol. Rev. 35, 790-819 (2011). doi: 10.1111/j.1574-6976.2011.00273.x; pmid: 21517914
31. B. F. Koel et al., Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976-979 (2013). doi: 10.1126/science.1244730; pmid: 24264991
32. B. Vrancken et al., The genealogical population dynamics of HIV-1 in a large transmission chain: Bridging within and among host evolutionary rates. PLOS Comput. Biol. 10, e1003505 (2014). pmid: 24699231
33. D. L. Ayres et al., BEAGLE: An application programming interface and high-performance computing library for statistical phylogenetics. Syst. Biol. 61, 170-173 (2012). doi: 10.1093/sysbio/syr100; pmid: 21963610
34. S. Telfer et al., Species interactions in a parasite community drive infection risk in a wildlife population. Science 330, 243-246 (2010). doi: 10.1126/science.1190333; pmid: 20929776
35. I. M. Cattadori et al., Infections do not predict shedding in co-infections with two helminths from a natural system. Ecology 95, 1684-1692 (2014). doi: 10.1890/13-1538.1; pmid: 25039232
36. R. Anderson, J. Truscott, T. D. Hollingsworth, The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths. Phil. Trans. R. Soc. B 369, 20130435 (2014). doi: 10.1098/rstb.2013.0435; pmid: 24821921
37. J. Lessler et al., Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLOS Pathog. 8, e1002802 (2012). doi: 10.1371/journal.ppat.1002802; pmid: 22829765
38. M. A. Miller, C. Viboud, M. Balinska, L. Simonsen, The signature features of influenza pandemics-implications for policy. N. Engl. J. Med. 360, 2595-2598 (2009). doi: 10.1056/NEJMp0903906; pmid: 19423872
39. J. S. Lavine, A. A. King, O. N. Bjørnstad, Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc. Natl. Acad. Sci. U.S.A. 108, 7259-7264 (2011). doi: 10.1073/pnas.1014394108; pmid: 21422281
40. S. Cobey, M. Lipsitch, Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335, 1376-1380 (2012). doi: 10.1126/science.1215947; pmid: 22383809
41. S. Gupta, R. M. Anderson, R. M. May, Networks of sexual contacts: Implications for the pattern of spread of HIV. AIDS 3, 807-817 (1989). doi: 10.1097/00002030-198912000-00005; pmid: 2517202
42. L. Danon et al., Networks and the epidemiology of infectious disease. Interdiscip. Perspect. Infect. Dis. 2011, 284909 (2011). doi: 10.1155/2011/284909; pmid: 21437001
43. S. Bansal, B. T. Grenfell, L. A. Meyers, When individual behaviour matters: Homogeneous and network models in epidemiology. J. R. Soc. Interface 4, 879-891 (2007). doi: 10.1098/rsif.2007.1100; pmid: 17640863
44. S. Bansal, J. Read, B. Pourbohloul, L. A. Meyers, The dynamic nature of contact networks in infectious disease epidemiology. J. Biol. Dyn. 4, 478-489 (2010). doi: 10.1080/17513758.2010.503376; pmid: 22877143
45. S. Funk, E. Gilad, C. Watkins, V. A. A. Jansen, The spread of awareness and its impact on epidemic outbreaks. Proc. Natl. Acad. Sci. U.S.A. 106, 6872-6877 (2009). doi: 10.1073/pnas.0810762106; pmid: 19332788
46. T. Oraby, V. Thampi, C. T. Bauch, The influence of social norms on the dynamics of vaccinating behaviour for paediatric infectious diseases. Proc. Biol. Sci. 281, 20133172 (2014). doi: 10.1098/rspb.2013.3172; pmid: 24523276
47. D. Centola, The spread of behavior in an online social network experiment. Science 329, 1194-1197 (2010). pmid: 20813952
48. M. Salathé, S. Khandelwal, Assessing vaccination sentiments with online social media: Implications for infectious disease dynamics and control. PLOS Comput. Biol. 7, e1002199 (2011). doi: 10.1371/journal.pcbi.1002199; pmid: 22022249
49. M. J. Ferrari et al., The dynamics of measles in sub-Saharan Africa. Nature 451, 679-684 (2008). doi: 10.1038/nature06509; pmid: 18256664
50. T. D. Hollingsworth, N. M. Ferguson, R. M. Anderson, Will travel restrictions control the international spread of pandemic influenza? Nat. Med. 12, 497-499 (2006). doi: 10.1038/nm0506-497; pmid: 16675989
51. T. A. Perkins, T. W. Scott, A. Le Menach, D. L. Smith, Heterogeneity, mixing, and the spatial scales of mosquito-borne pathogen transmission. PLOS Comput. Biol. 9, e1003327 (2013). pmid: 24348223
52. A. Wesolowski et al., Quantifying the impact of human mobility on malaria. Science 338, 267-270 (2012). doi: 10.1126/science.1223467; pmid: 23066082
53. R. Ross, The Prevention of Malaria (John Murray, London, ed. 2, 1911).
54. M. S. Bartlett, Measles periodicity and community size. J. R. Stat. Soc. Ser A 120, 48-70 (1957). doi: 10.2307/2342553
55. R. M. Anderson, R. M. May, Directly transmitted infections diseases: Control by vaccination. Science 215, 1053-1060 (1982). doi: 10.1126/science.7063839; pmid: 7063839
56. A. R. McLean, R. M. Anderson, Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol. Infect. 100, 419-442 (1988). doi: 10.1017/S0950268800067170; pmid: 3378585
57. D. S. Saint-Victor, S. B. Omer, Vaccine refusal and the endgame: Walking the last mile first. Phil. Trans. R. Soc. B 368, 20120148 (2013). doi: 10.1098/rstb.2012.0148; pmid: 23798696
58. P. Klepac, R. Laxminarayan, B. T. Grenfell, Synthesizing epidemiological and economic optima for control of immunizing infections. Proc. Natl. Acad. Sci. U.S.A. 108, 14366-14370 (2011). doi: 10.1073/pnas.1101694108; pmid: 21825129
59. M. Salathé et al., Digital epidemiology. PLOS Comput. Biol. 8, e1002616 (2012). doi: 10.1371/journal.pcbi.1002616; pmid: 22844241
60. M. Salathé, C. C. Freifeld, S. R. Mekaru, A. F. Tomasulo, J. S. Brownstein, Influenza A (H7N9) and the importance of digital epidemiology. N. Engl. J. Med. 369, 401-404 (2013). doi: 10.1056/NEJMp1307752; pmid: 23822655
61. A. F. Read, P. A. Lynch, M. B. Thomas, How to make evolution-proof insecticides for malaria control. PLOS Biol. 7, e1000058 (2009). doi: 10.1371/journal.pbio.1000058; pmid: 19355786
62. N. Arinaminpathy, J. S. Lavine, B. T. Grenfell, Self-boosting vaccines and their implications for herd immunity. Proc. Natl. Acad. Sci. U.S.A. 109, 20154-20159 (2012). doi: 10.1073/pnas.1209683109; pmid: 23169630
63. O. Diekmann, J. A. P. Heesterbeek, T. Britton, Mathematical Tools for Understanding Infectious Disease Dynamics (Princeton Univ. Press, Princeton, 2013).
64. C. P. Jewell, G. O. Roberts, Enhancing Bayesian risk prediction for epidemics using contact tracing. Biostatistics 13, 567-579 (2012). doi: 10.1093/biostatistics/kxs012; pmid: 22674466
65. E. S. Knock, P. D. O 'Neill, Bayesian model choice for epidemic models with two levels of mixing. Biostatistics 15, 46-59 (2014). doi: 10.1093/biostatistics/kxt023; pmid: 23887980
66. J. Dureau, K. Kalogeropoulos, M. Baguelin, Capturing the time-varying drivers of an epidemic using stochastic dynamical systems. Biostatistics 14, 541-555 (2013). doi: 10.1093/biostatistics/kxs052; pmid: 23292757
67. A. A. King, E. L. Ionides, M. Pascual, M. J. Bouma, Inapparent infections and cholera dynamics. Nature 454, 877-880 (2008). doi: 10.1038/nature07084; pmid: 18704085
68. O. Ratmann, G. Donker, A. Meijer, C. Fraser, K. Koelle, Phylodynamic inference and model assessment with approximate bayesian computation: Influenza as a case study. PLOS Comput. Biol. 8, e1002835 (2012). doi: 10.1371/journal.pcbi.1002835; pmid: 23300420
69. M. Farah, P. J. Birrell, S. Conti, D. De Angelis, Bayesian Emulation and Calibration of a Dynamic Epidemic Model for A/H1N1 Influenza. J. Am. Stat. Assoc. 109, 1398-1411 (2014). doi: 10.1080/01621459.2014.934453
70. M. Baguelin et al., Assessing optimal target populations for influenza vaccination programmes: An evidence synthesis and modelling study. PLOS Med. 10, e1001527 (2013). doi: 10.1371/journal.pmed.1001527; pmid: 24115913
71. D. De Angelis, A. M. Presanis, S. Conti, A. E. Ades, Estimation of HIV Burden through Bayesian Evidence Synthesis. Stat. Sci. 29, 9-17 (2014). doi: 10.1214/13-STS428
72. J. Ginsberg et al ., Detecting influenza epidemics using search engine query data. Nature 457, 1012-1014 (2009). doi: 10.1038/nature07634; pmid: 19020500
73. N. Bharti et al., Explaining seasonal fluctuations of measles in Niger using nighttime lights imagery. Science 334, 1424-1427 (2011). doi: 10.1126/science.1210554; pmid: 22158822
74. J. P. Messina et al., Global spread of dengue virus types: Mapping the 70 year history. Trends Microbiol. 22, 138-146 (2014). doi: 10.1016/j.tim.2013.12.011; pmid: 24468533
75. C. Dye et al., WHO and the future of disease control programmes. Lancet 381, 413-418 (2013). doi: 10.1016/S0140-6736(12)61812-1; pmid: 23374479
76. C. Dye, After 2015: Infectious diseases in a new era of health and development. Philos. Trans. R. Soc. Lond. B 369, 20130426 (2014). doi: 10.1098/rstb.2013.0426; pmid: 24821913
77. M. Woolhouse, J. Farrar, Policy: An intergovernmental panel on antimicrobial resistance. Nature 509, 555-557 (2014). doi: 10.1038/509555a; pmid: 24877180
78. R. F. Terry, J. F. Salm Jr., C. Nannei, C. Dye, Creating a global observatory for health R&D. Science 345, 1302-1304 (2014). doi: 10.1126/science.1258737; pmid: 25214621
79. P. Rohani, A. A. King, Never mind the length, feel the quality: The impact of long-term epidemiological data sets on theory, application and policy. Trends Ecol. Evol. 25, 611-618 (2010). doi: 10.1016/j.tree.2010.07.010; pmid: 20800928
80. M. E. Halloran, I. M. Longini, C. J. Struchiner, Design and Analysis of Vaccine studies (Springer, Berlin, 2010).
81. M. L. Ndeffo Mbah et al., Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc. Natl. Acad. Sci. U.S.A. 110, 7952-7957 (2013). doi: 10.1073/pnas.1221396110; pmid: 23589884
82. R. Pitman et al., Dynamic transmission modeling: A report of the ISPOR-SMDM modeling good research practices task force-5. Value Health 15, 828-834 (2012). doi: 10.1016/j.jval.2012.06.011; pmid: 22999132
83. M. E. J. Woolhouse et al., Guide to good practice for quantitative veterinary epidemiology. www.qve-goodpracticeguide.org.uk/ (2011).
84. T. D. Hollingsworth, D. Klinkenberg, H. Heesterbeek, R. M. Anderson, Mitigation strategies for pandemic influenza A: Balancing conflicting policy objectives. PLOS Comput. Biol. 7, e1001076 (2011). doi: 10.1371/journal.pcbi.1001076; pmid: 21347316
85. J. T. Wu, B. J. Cowling, The use of mathematical models to inform influenza pandemic preparedness and response. Exp. Biol. Med. 236, 955-961 (2011). doi: 10.1258/ebm.2010.010271; pmid: 21727183
86. B. Y. Lee, A. E. Wiringa, The 2009 H1N1 influenza pandemic: A case study of how modeling can assist all stages of vaccine decision-making. Hum. Vaccin. 7, 115-119 (2011). doi: 10.4161/hv.7.1.13740; pmid: 21263227
87. M. Lipsitch, L. Finelli, R. T. Heffernan, G. M. Leung, S. C. Redd; 2009 H1n1 Surveillance Group, Improving the evidence base for decision making during a pandemic: The example of 2009 influenza A/H1N1. Biosecur. Bioterror. 9, 89-115 (2011). pmid: 21612363
88. T. House et al., Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proc. Biol. Sci. 278, 2753-2760 (2011). doi: 10.1098/rspb.2010.2688; pmid: 21288945
89. M. D. Van Kerkhove, N. M. Ferguson, Epidemic and intervention modelling-a scientific rationale for policy decisions? Lessons from the 2009 influenza pandemic. Bull. World Health Organ. 90, 306-310 (2012). pmid: 22511828
90. M. Luksza, M. Lässig, A predictive fitness model for influenza. Nature 507, 57-61 (2014). doi: 10.1038/nature13087; pmid: 24572367
91. UK Government, (2012, https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/224775/JCVI-statement-on-the-annual-influenza-vaccination-programme-25-July-2012.pdf).
92. M. A. Rose et al., The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: Predictions of a simulation study. BMC Infect. Dis. 14, 40 (2014). doi: 10.1186/1471-2334-14-40; pmid: 24450996
93. HIV Modelling Consortium Treatment as Prevention Editorial Writing Group, HIV treatment as prevention: Models, data, and questions-towards evidence-based decision-making. PLOS Med. 9, e1001259 (2012). doi: 10.1371/journal. pmed.1001259; pmid: 22802739
94. A. S. Perelson, A. U. Neumann, M. Markowitz, J. M. Leonard, D. D. Ho, HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586 (1996). doi: 10.1126/science.271.5255.1582; pmid: 8599114
95. N. R. Faria et al., The early spread and epidemic ignition of HIV-1 in human populations. Science 346, 56-61 (2014). doi: 10.1126/science.1256739; pmid: 25278604
96. T. D. Hollingsworth, R. M. Anderson, C. Fraser, HIV-1 transmission, by stage of infection. J. Infect. Dis. 198, 687-693 (2008). doi: 10.1086/590501; pmid: 18662132
97. D. Bezemer et al., A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 22, 1071-1077 (2008). doi: 10.1097/QAD.0b013e3282fd167c; pmid: 18520351
98. J. S. Montaner et al., The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368, 531-536 (2006). doi: 10.1016/S0140-6736(06)69162-9; pmid: 16890841
99. R. M. Granich, C. F. Gilks, C. Dye, K. M. De Cock, B. G. Williams, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373, 48-57 (2009). doi: 10.1016/S0140-6736(08)61697-9; pmid: 19038438
100. M. S. Cohen et al., Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365, 493-505 (2011). doi: 10.1056/NEJMoa1105243; pmid: 21767103
101. S. E. Bellan et al., Extra-couple HIV transmission in sub-Saharan Africa: A mathematical modelling study of survey data. Lancet 381, 1561-1569 (2013). doi: 10.1016/S0140-6736(12)61960-6; pmid: 23391466
102. F. Tanser, T. Bärnighausen, E. Grapsa, J. Zaidi, M. L. Newell, High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 339, 966-971 (2013). doi: 10.1126/science.1228160; pmid: 23430656
103. S. H. Vermund, S. J. Fidler, H. Ayles, N. Beyers, R. J. Hayes, Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia. J. Acquir. Immune Defic. Syndr. 63 (suppl. 2), S221-S227 (2013). doi: 10.1097/QAI.0b013e318299c3f4; pmid: 23764639
104. M. K. Smith, K. A. Powers, K. E. Muessig, W. C. Miller, M. S. Cohen, HIV treatment as prevention: The utility and limitations of ecological observation. PLOS Med. 9, e1001260 (2012). doi: 10.1371/journal.pmed.1001260; pmid: 22802740
105. M. S. Cohen et al., Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: Where do we go from here? Lancet 382, 1515-1524 (2013). doi: 10.1016/S0140-6736(13)61998-4; pmid: 24152938
106. G. MacDonald, The analysis of equilibrium in malaria. Trop. Dis. Bull. 49, 813-829 (1952). pmid: 12995455
107. K. Dietz, L. Molineaux, A. Thomas, A malaria model tested in the African savannah. Bull. World Health Organ. 50, 347-357 (1974). pmid: 4613512
108. R. M. Anderson, R. M. May, Infectious Diseases of Humans: Dynamics and Control (Oxford Univ. Press, Oxford, 1992).
109. A. S. Perelson, R. M. Ribeiro, Modeling the within-host dynamics of HIV infection. BMC Biol. 11, 96 (2013). doi: 10.1186/1741-7007-11-96; pmid: 24020860
110. C. A. Donnelly, N. M. Ferguson, 2000, Statistical Aspects of BSE and vCJD: Models for Epidemics (Chapman & Hall/CRC, Boca Raton, FL, 2000).
111. M. J. Keeling, Models of foot-and-mouth disease. Proc. Biol. Sci. 272, 1195-1202 (2005). doi: 10.1098/rspb.2004.3046; pmid: 16024382
112. R. M. Anderson et al., Epidemiology, transmission dynamics and control of SARS: The 2002-2003 epidemic. Phil. Trans. R. Soc. B 359, 1091-1105 (2004). doi: 10.1098/rstb.2004.1490; pmid: 15306395
113. S. Blumberg, J. O. Lloyd-Smith, Comparing methods for estimating R0 from the size distribution of subcritical transmission chains. Epidemics 5, 131-145 (2013). doi: 10.1016/j.epidem.2013.05.002; pmid: 24021520
114. J. O. Lloyd-Smith, S. J. Schreiber, P. E. Kopp, W. M. Getz, Superspreading and the effect of individual variation on disease emergence. Nature 438, 355-359 (2005). doi: 10.1038/nature04153; pmid: 16292310
115. L. Matthews et al., Heterogeneous shedding of Escherichia coli O157 in cattle and its implications for control. Proc. Natl. Acad. Sci. U.S.A. 103, 547-552 (2006). doi: 10.1073/pnas.0503776103; pmid: 16407143
116. N. M. Ferguson, A. P. Galvani, R. M. Bush, Ecological and immunological determinants of influenza evolution. Nature 422, 428-433 (2003). doi: 10.1038/nature01509; pmid: 12660783
117. K. Koelle, S. Cobey, B. Grenfell, M. Pascual, Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314, 1898-1903 (2006). doi: 10.1126/science.1132745; pmid: 17185596
118. M. Recker, O. G. Pybus, S. Nee, S. Gupta, The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc. Natl. Acad. Sci. U.S.A. 104, 7711-7716 (2007). doi: 10.1073/pnas.0702154104; pmid: 17460037
119. S. Funk, H. Nishiura, H. Heesterbeek, W. J. Edmunds, F. Checchi, Identifying transmission cycles at the human-animal interface: The role of animal reservoirs in maintaining gambiense human african trypanosomiasis. PLOS Comput. Biol. 9, e1002855 (2013). doi: 10.1371/journal.pcbi.1002855; pmid: 23341760
120. R. C. Reiner Jr. et al., A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010. J. R. Soc. Interface 10, 20120921 (2013). doi: 10.1098/rsif.2012.0921; pmid: 23407571
121. E. M. Stuckey, T. A. Smith, N. Chitnis, Estimating malaria transmission through mathematical models. Trends Parasitol. 29, 477-482 (2013). doi: 10.1016/j.pt.2013.08.001; pmid: 24001452
122. N. G. Reich et al., Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J. R. Soc. Interface 10, 20130414 (2013). doi: 10.1098/rsif.2013.0414; pmid: 23825116
123. B. S. Cooper et al., Methicillin-resistant Staphylococcus aureus in hospitals and the community: Stealth dynamics and control catastrophes. Proc. Natl. Acad. Sci. U.S.A. 101, 10223-10228 (2004). doi: 10.1073/pnas.0401324101; pmid: 15220470
124. C. Dye, B. G. Williams, The population dynamics and control of tuberculosis. Science 328, 856-861 (2010). doi: 10.1126/science.1185449; pmid: 20466923
125. A. F. Read, T. Day, S. Huijben, The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc. Natl. Acad. Sci. U.S.A. 108 (suppl. 2), 10871-10877 (2011). doi: 10.1073/pnas.1100299108; pmid: 21690376
126. S. Cobey, M. Lipsitch, Pathogen diversity and hidden regimes of apparent competition. Am. Nat. 181, 12-24 (2013). doi: 10.1086/668598; pmid: 23234842
127. C. J. E. Metcalf et al., Structured models of infectious disease: Inference with discrete data. Theor. Popul. Biol. 82, 275-282 (2012). doi: 10.1016/j.tpb.2011.12.001; pmid: 22178687
128. J. Lessler, C. J. E. Metcalf, Balancing evidence and uncertainty when considering rubella vaccine introduction. PLOS ONE 8, e67639 (2013). doi: 10.1371/journal. pone.0067639; pmid: 23861777
129. R. Anderson, T. D. Hollingsworth, J. Truscott, S. Brooker, Optimisation of mass chemotherapy to control soil-transmitted helminth infection. Lancet 379, 289-290 (2012). doi: 10.1016/S0140-6736(12)60120-2; pmid: 22284644
130. C. J. E. Metcalf et al., Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa. J. R. Soc. Interface 10, 20120756 (2013). doi: 10.1098/rsif.2012.0756; pmid: 23152104
131. T. Panagiotopoulos, I. Antoniadou, E. Valassi-Adam, A. Berger, Increase in congenital rubella occurrence after immunisation in Greece: Retrospective survey and systematic review. BMJ 319, 1462-1467 (1999). doi: 10.1136/bmj.319.7223.1462; pmid: 10582926
132. C. H. Chan, C. J. McCabe, D. N. Fisman, Core groups, antimicrobial resistance and rebound in gonorrhoea in North America. Sex. Transm. Infect. 88, 200-204 (2012). doi: 10.1136/sextrans-2011-050049; pmid: 22169277
133. Y. Nagao, K. Koelle, Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc. Natl. Acad. Sci. U.S.A. 105, 2238-2243 (2008). doi: 10.1073/pnas.0709029105; pmid: 18250338